Based on record review and interview, it was determined that for one (R28) out of five residents reviewed for medication review, the facility failed to ensure the provider documented that irregularities were reviewed. Findings include:Review of R28's clinical record revealed:9/26/18 - R28 was admitted to the facility. 7/10/24 - A physician's order documented divalproex sodium (anticonvulsant) 500 mg give one tablet daily at bed time for bipolar mood stabilization.10/2/24 - A physician's order documented buspirone 15 mg (anti-anxiety) twice a day for anxiety. 10/7/25 - A monthly medication regimen review (MRR) documented a recommendation to attempt dose reduction on divalproex to 250 mg. The MRR lacked physician's signature and acknowledgement the recommendations were reviewed. …
F756 citations in Delaware
Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Delaware cites F756 more often than its own record predicts
1.61 times the share F756 takes of citations nationally.
Of every deficiency written in Delaware in 2025, this is the portion that was F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Delaware surveyors wrote
F756 findings written in Delaware, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on review of facility documentation and interview, it was determined that the facility failed to ensure that the monthly drug regimen review policy included time frames for the different steps in the process and steps the pharmacist must take when he or she identifies an irregularity that requires urgent action to protect the resident.12/5/20 - A facility document entitled, Medication Regimen Review, revised 8/31/21, 2/23/23, 7/15/24, and 8/6/25, documented, Medications are reviewed in multiple ways including, but not limited to the MRR conducted by the consultant pharmacist 8/27/25 11:27 AM - A review of the facility's Medication Regimen Review lacked evidence of the time frames for the different steps in the process and steps the pharmacist must take when an irregularity is… …
The short window
Recent years
| Year | Share of Delaware citations | vs expected |
|---|---|---|
| 2023 | 2.91% | 3.09× |
| 2024 | 1.40% | 1.72× |
| 2025 | 1.28% | 1.61× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Delaware surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction